Heart failure due to chronic iron overload is a leading cause of cardiovascular mortality in the second and third decades of life worldwide, but its mechanism is not known. Deficiencies of selenium have been shown to result in damage to the myocardium and to the development of various cardiomyopathies. In the current investigation, the dose-dependent effects of chronic iron toxicosis on heart tissue concentrations of selenium and the protective antioxidant enzyme glutathione peroxidase (GPx) were investigated in a murine model of iron-overload cardiomyopathy (n = 20). Significant dose-dependent decreases in heart tissue selenium concentrations (r =-0.95, p <0.001) and selenium-dependent GPx activity (r =-0.93, p <0.001) were observed in chronically iron-loaded mice in comparison with placebo controls. These results suggest that dietary supplementation with selenium may be beneficial in the clinical management of disorders of iron metabolism.
Get full access to this article
View all access options for this article.
References
1.
Adams, P. C. , & Valberg, L. S. (1996). Evolving expression of hereditary hemochromatosis. Seminars in Liver Disease, 16, 47-54.
2.
Aldouri, M. A. , Hoffbrand, A. V., Flynn, D. M., Ward, S. E., Agnew, J. E., & Hilson, A.J.W. (1994). High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusions and iron chelation: Reversal by intensified chelation. Acta Haematology, 84, 113-123.
3.
Andrews, N. C. (1999). Disorders of iron metabolism. The New England Journal of Medicine, 341, 1986-1995.
4.
Arthur, J. R. (2000). The glutathione peroxidases. Cellular and Molecular Life Sciences, 57, 1825-1835.
5.
Ball, A. , & Sole, M. J. (1998). Oxidative stress and the pathogenesis of heart failure. Cardiology Clinics, 16, 665-675.
6.
Bartfay, W. J. ,&Bartfay, E. (2000a). Iron-overload cardiomyopathy: Evidence for a free radical-mediated mechanism of injury and dysfunction in a murine model. Biological Research for Nursing, 2(1), 1-11.
7.
Bartfay, W. J. ,&Bartfay, E. (2000b). Systemic oxygen-free radical production in iron-loaded mice. Western Journal of Nursing Research, 22, 927-935.
8.
Bartfay, W. J. ,&Bartfay, E. (2001). Selenium and glutathione peroxidase with beta-thalassemia major. Nursing Research, 50(3), 178-183.
9.
Bartfay, W. J. , Butany, J., Lehotay, D. C., Sole, M. J., Hou, D., Bartfay, E., et al. (1999). A biochemical, histochemical, and electron microscopic study on the effects of iron-loading in heart of mice. Cardiovascular Pathology, 8(6), 305-314.
10.
Bartfay, W. J. , Dawood, F. D., Wen, W. H., Lehotay, D. C., Hou, D., Bartfay, E., et al. (1999). Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload. Cardiovascular Research, 43, 892-900.
11.
Bartfay, W. J. , Hou, D., Lehotay, D. C., Bartfay, E., Luo, X., & Liu, P. (2000). Cardioprotective effects of selenium and morin hydrate in a murine model of chronic iron overload. The Journal of Trace Elements in Experimental Medicine, 13, 285-297.
12.
Bartfay, W. J. , Lehotay, D. C., Sher, G. D., Bartfay, E., Tyler, B., Luo, X. P., et al. (1999). Comparison of cytotoxic aldehyde generation in beta-thalassemia patients chelated with deferoxamine or deferiprone (L1) versus no chelation. Hematology, 4, 67-76.
13.
Bothwell, T. H. , & MacPhail, A. P. (1998). Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects. Seminars in Hematology, 35, 55-71.
14.
Burkitt, M. J. , & Mason, R. P. (1991). Direct evidence for in vivo hydroxyl generation in experimental iron overload: An ESR spin-trapping investigation. Proceedings of the National Academy of Science, 88, 8440-8444.
15.
Byler, R. M. , Sherman, N. A., Wallner, J. S., & Horwitz, L. D. (1994). Hydrogen peroxide cytotoxicity is iron dependent. American Journal of Physiology, 35, H121-H127.
16.
Chareonpong-Kawamoto, N. ,&Yasumoto, K. (1995). Selenium deficiency as a cause of overload of iron and unbalance distribution of other minerals. Bioscience, Biotechnology and Biochemistry, 59, 302-306.
17.
Chau, L.Y. (2000). Iron and atherosclerosis. Proceedings of the National Science Council, 24(4), 151-155.
18.
Chen, H. , & Tappel, A. L. (1993). Protection of heme proteins by vitamin E, selenium, and betacarotene against oxidative damage in rat heart, kidney, lung and spleen. Free Radical Research Communications, 19, 183-190.
19.
Chen, S.Y. , Collipp, P. J., & Hsu, J. M. (1987). The effect of selenium toxicity on tissue distribution of zinc, iron, and copper in rats. In G. F. Combs, J. E. Spallholz, J. E., O. A. Levander,& J. E. Oldfied (Eds.), Selenium in biology and medicine (pp. 367-376). New York: Van Nostrand Reinhold.
20.
Chyka, P. A. , Butler, A. Y., & Holley, J. E. (1996). Serum iron concentrations and symptoms of acute iron poisoning in children. Pharmacotherapy, 16, 1053-1058.
21.
Dabbagh, A. J. , Mannion, T., Lynch, S. M., & Frei, B. (1994). The effect of iron overload on rat plasma and liver oxidant status in-vivo. Biochemistry Journal, 300, 799-803.
22.
Demougeot, C. , Marie, C., & Beley, A. (2000). Importance of iron location in iron-induced hydroxyl radical production by brain slices. Life Sciences, 67, 399-410.
23.
Der, G. , & Everitt, D. (2001). A handbook of statistical analysis using SAS (2nd ed). Boca Raton, FL: Chapman & Hall/CRC Press.
24.
Dworkin, B. M. (1994). Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chemico-Biology International, 91, 181-186.
25.
Feder, J. N. , Gnirke, A., & Thomas, W. (1996). A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399-408.
26.
Fenton, H.J.H. (1894). Oxidation of tartaric acid in the presence of iron. Journal of Chemical Society, 65, 899-903.
27.
Frost, D. V. (1980). Selenium and vitamin E as antidotes to heavy metal toxicities. In J. E. Spallholz, J. L. Martin,& H. E. Ganther (Eds.), Selenium in biology and medicine (pp. 490-498). Westport, CT: AVI.
28.
Goyer, R. A. (1995). Nutrition and metal toxicity. American Journal of Clinical Nutrition, 61, 646S-650S.
29.
Haber, F. , & Weiss, J. (1934). The catalytic decomposition of hydrogen peroxide by iron salts. Proceedings of the Royal Society London, 147(Series A), 332-351.
30.
Halliwell, B. (1997). Antioxidants and human disease: A general introduction. Nutrition Reviews, 55, S44-S52.
31.
Halliwell, B. , & Gutteridge, J.M.C. (1990). Role of free radicals and catalytic metal ions in human disease. An overview. Methods in Enzymology, 186, 1-85.
32.
Herbert, V. , Shaw, S., Jayatilleke, E., & Stopler-Kasdan, T. (1994). Most free radical injury is iron-related. It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells, 12, 289-303.
33.
Hershko, C. , Link, G., & Cabantchik, I. (1998). Pathophysiology of iron overload. Annuals of the New York Academy of Sciences, 850, 191-201.
34.
Horwitz, D. L. , & Rosenthal, E. A. (1999). Iron-mediated cardiovascular injury. Vascular Medicine, 4, 93-99.
35.
Houglum, K. , Filip, M., Witztum, J.,& Chojkier, M. (1991). Malondialdehyde and 4-hydroxynoneneal protein adducts in plasma of rats with iron overload. Journal of Clinical Investigations, 86, 1991-1998.
36.
Kehrer, J. P. (2000). The Haber-Weiss reaction and mechanisms of toxicity. Toxicology, 149, 43-50.
37.
Kennedy, S. , & Rice, D. A. (1989). Selective damage to cardiac conduction system in vitamin E and selenium deficient calves. Annuals of the New York Academy of Sciences, 570, 467-469.
38.
Knowles, M.B. ,&Brodie, K. G. (1988). Determination of selenium in blood by Zeeman graphic furnace atomic absorption spectrometry using palladium-ascorbic acid chemical modifier. Journal of Analytical Atomic Spectrometry, 3, 511-516.
39.
Konz, K. H. , Haap, M., Hill, K. E., Burk, R. F., & Walsh, R. A. (1989). Diastolic dysfunction of perfused rat hearts induced by hydrogen peroxide. Protective effect of selenium. Journal of Molecular and Cellular Cardiology, 21, 789-795.
40.
Lawrence, D. , & Rosenthal, E. A. (1999). Iron-mediated cardiovascular injury. Vascular Medicine, 4, 93-99.
41.
Lesnefsky, E. J. (1994). Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Advances in Experimental Medicine and Biology, 366, 129-146.
42.
Liu, P. , Henkleman, R. M., Joshi, J., Hardy, P., Butany, J., Iwanochko, M., et al. (1996). Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel thalassemia-cardiac iron overload model. Canadian Journal of Cardiology, 12, 155-164.
43.
Liu, P. , & Olivieri, N. (1994). Iron overload cardiomyopathies: New insights into an old disease. Cardiovascular Drugs and Therapy, 8, 101-110.
44.
Livrea, M. A. , Tesoriere, L., Pintaudi, A. M., Calabrese, A., Maggio, A., Freisleben, H. J., et al. (1996). Oxidative stress and antioxidant status in beta-thalassemia major: Iron overload and depletion of lipid soluble antioxidants. Blood, 88, 3608-3614.
45.
Lockitch, G. , Taylor, G. P., & Wong, L.T.K. (1990). Cardiomyopathy associated with nonendemic selenium deficiency in a Caucasian adolescent. American Journal of Clinical Nutrition, 52, 572-577.
46.
Lynch, S. R. (1995). Iron-overload: Prevalence and impact on health. Nutrition Reviews, 53, 255-260.
47.
Madani, T.A.A. ,&Bormanis, J. (1997). Reversible severe hereditary hemochromatotic cardiomyopathy. Canadian Journal of Cardiology, 13(4), 391-394.
48.
McCord, J. M. (1996). Effects of iron status at a cellular level. Nutrition Reviews, 54, 85-88.
49.
McMaster, D. , Bell, N., Anderson, P., & Hg-Love, A. (1990). Automated measurements of two indicators of human selenium status and applicability to population study. Clinical Chemistry, 36, 211-216.
50.
Meneghini, R. (1997). Iron homeostasis, oxidative stress, and DNA damage. Free Radical Biology and Medicine, 23, 783-792.
51.
Montgomery, D. C. (1991). Design and analysis of experiments (3rd ed.). New York: John Wiley.
52.
Myers, M. L. , Farhangkhoee, P.,&Karmazyn, M. (1998). Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642. Cardiovascular Research, 40, 290-296.
53.
Olfert, E. D. , Cross, B. M., & McWilliams, A. A. (1993). Canadian Council on Animal Care: Guide to the care and use of experimental animals (2nd ed.). Ottawa, Ontario: Bradda Printing Services.
54.
Olivieri, N. F. (1999). The β-thalassemias. The New England Journal of Medicine, 341(2), 99-109.
55.
Olivieri, N. F. ,&Brittenham, G. M. (1997). Iron-chelating therapy and the treatment of thalassemia. Blood, 89, 281-284.
56.
Parkkila, S. , Niemela, O., Britton, R. S., Brown, K. E.,&Yla-Herttuala, S. (1996). Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron-overload. American Journal of Physiology, 270, G376-G384.
57.
Persson-Moschos, M. (2000). Selenoprotein P. Cellular and Molecular Life Sciences, 57, 1836-1845.
58.
Pucheu, S. , Coudray, C., Tressallet, N., Favier, A., & de Leiris, J. (1993). Effect of iron overload in the isolated ischemic and reperfused rat heart. Cardiovascular Drugs and Therapy, 7, 701-711.
59.
Quercia, R. A. , Korn, S., O’Neill, D., Dougherty, J. E., Ludwig, M., Schweizer, R., et al. (1984). Selenium deficiency and fatal cardiomyopathy in a person receiving long-term home parenteral nutrition. Clinical Pharmacology, 3, 531-535.
60.
Read, R. , Bellew, T., Yang, J. G., Hill, K. E., Palmer, I. S.,&Burk, R. F. (1990). Selenium and amino acid composition of selenoprotein P, the major selenoprotein in rat serum. Journal of Biology and Chemistry, 265, 17899-17905.
61.
Ringstad, J. , Tande, P. M., Norheim, G., & Refsum, H. (1988). Selenium deficiency and cardiac electrophysiological and mechanical function in the rat. Pharmacology and Toxicology, 63, 189-192.
62.
Sasakura, C. , & Suzuki, K. T. (1998). Biological interaction between transition metals (Ag, Cd and Hg), selenide/sulfide and selenoprotein P. Journal of Inorganic Biochemistry, 71(3-4), 159-162.
63.
Simoni, J. , Simoni, G., Barcia, E. L., Prien, S. D., Tran, R. M., Feola, M., et al. (1995). Protective effect of selenium on hemoglobin mediated lipid peroxidation in-vivo. Artificial Cells, Blood Substitutes and Immobilization Biotechnology, 23, 469-486.
64.
Singal, P. K. , Khaper, N., Palace, V.,&Kumar, D. (1998). The role of oxidative stress in the genesis of heart disease. Cardiovascular Research, 40, 426-432.
65.
Westfall, P. H. , Tobias, R. D., Rom, D., Walfinger, R. D., & Hochberg, Y. (1999). Multiple comparisons and multiple tests using the SAS system. Cary, NC: SAS Publications.
66.
Whanger, P. D. (1993). Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis. Journal of Trace Elements, Electrolytes, Health and Disease, 6, 209-221.
67.
Whanger, P. D. (2000). Selenoprotein W: A review. Cellular and Molecular Life Sciences, 57, 1846-1845.
68.
Young, I. S. , Trouton, T. G., Torney, J. J., McMaster, D., Callender, M., & Trimble, E. R. (1994). Antioxidant status and lipid peroxidation in hereditary hemochromatosis. Free Radical Biology and Medicine, 16, 393-397.
69.
Ytrehus, K. , Ringstad, J., Myklebust, R., Norheim, G., & Mjos, O. D. (1988). The selenium-deficient rat heart with special reference to tolerance against enzymatically generated oxygen radicals. Scandinavian Journal of Clinical and Laboratory Investigations, 48, 289-295.
70.
Zachara, B. (1992). Mammalian selenoproteins. Journal of Trace Element, Electrolytes, Health and Disease, 6, 137-151.
